Title | Type | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.793 Q1 | 247 | 32 | 98 | 14357 | 2110 | 98 | 20.52 | 448.66 | |
2 | Medicinal Research Reviews | journal | 3.064 Q1 | 141 | 37 | 112 | 7413 | 1108 | 111 | 9.61 | 200.35 | |
3 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.164 Q1 | 79 | 15 | 42 | 2911 | 243 | 42 | 5.67 | 194.07 | |
4 | Pharmacology and Therapeutics | journal | 4.225 Q1 | 220 | 119 | 320 | 22603 | 3661 | 319 | 12.17 | 189.94 | |
5 | Advances in Molecular Toxicology | book series | 0.322 Q3 | 17 | 8 | 22 | 1420 | 33 | 0 | 0.79 | 177.50 | |
6 | Advances in Delivery Science and Technology | book series | 2 | 5 | 0 | 875 | 0 | 0 | 0.00 | 175.00 | ||
7 | Studies in Natural Products Chemistry | book series | 0.345 Q3 | 45 | 35 | 115 | 6113 | 131 | 16 | 1.08 | 174.66 | |
8 | Critical Reviews in Toxicology | journal | 1.806 Q1 | 122 | 32 | 137 | 5226 | 785 | 122 | 5.68 | 163.31 | |
9 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.777 Q1 | 69 | 6 | 23 | 963 | 126 | 23 | 5.46 | 160.50 | |
10 | Drug Resistance Updates | journal | 3.961 Q1 | 125 | 22 | 45 | 3481 | 504 | 42 | 8.79 | 158.23 | |
11 | Natural Product Reports | journal | 3.471 Q1 | 200 | 77 | 228 | 12047 | 2414 | 222 | 10.82 | 156.45 | |
12 | Topics in Medicinal Chemistry | book series | 0.214 Q3 | 14 | 21 | 43 | 3177 | 25 | 39 | 0.41 | 151.29 | |
13 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 2.483 Q1 | 94 | 12 | 52 | 1775 | 338 | 47 | 6.31 | 147.92 | |
14 | Advanced Drug Delivery Reviews | journal | 5.054 Q1 | 348 | 174 | 485 | 24836 | 8390 | 436 | 15.79 | 142.74 | |
15 | Advances in Pharmacology | journal | 1.837 Q1 | 81 | 33 | 120 | 4514 | 449 | 0 | 3.43 | 136.79 | |
16 | Current Drug Metabolism | journal | 0.977 Q2 | 118 | 72 | 301 | 9288 | 1018 | 275 | 3.11 | 129.00 | |
17 | Drug Metabolism Reviews | journal | 1.948 Q1 | 105 | 35 | 81 | 4484 | 464 | 77 | 4.56 | 128.11 | |
18 | Current Medicinal Chemistry | journal | 0.856 Q2 | 192 | 275 | 1185 | 34914 | 4720 | 1120 | 3.74 | 126.96 | |
19 | Cellular and Molecular Life Sciences | journal | 3.400 Q1 | 248 | 307 | 905 | 38487 | 5679 | 894 | 6.34 | 125.36 | |
20 | Handbook of Experimental Pharmacology | journal | 1.672 Q1 | 103 | 154 | 348 | 18335 | 1391 | 334 | 4.02 | 119.06 | |
21 | Progress in Drug Research | book series | 0.888 Q1 | 44 | 8 | 23 | 941 | 62 | 19 | 2.70 | 117.63 | |
22 | Progress in Medicinal Chemistry | journal | 1.504 Q1 | 37 | 6 | 16 | 705 | 71 | 0 | 5.00 | 117.50 | |
23 | Annual Review of Pharmacology and Toxicology | journal | 8.547 Q1 | 218 | 33 | 80 | 3820 | 1456 | 79 | 16.52 | 115.76 | |
24 | Chemotherapy Research and Practice | journal | 0.182 Q3 | 5 | 1 | 3 | 113 | 5 | 3 | 1.67 | 113.00 | |
25 | Current Pharmaceutical Design | journal | 1.242 Q1 | 176 | 614 | 1877 | 67431 | 6185 | 1727 | 3.19 | 109.82 | |
26 | Cancer Drug Discovery and Development | book series | 7 | 47 | 18 | 5099 | 4 | 17 | 0.22 | 108.49 | ||
27 | Pharmaceutical Nanotechnology | journal | 0.338 Q2 | 18 | 5 | 5 | 534 | 6 | 5 | 1.20 | 106.80 | |
28 | Current Neuropharmacology | journal | 1.392 Q1 | 93 | 77 | 127 | 8032 | 534 | 118 | 4.09 | 104.31 | |
29 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.477 Q3 | 50 | 9 | 97 | 936 | 117 | 75 | 0.41 | 104.00 | |
30 | Expert Opinion on Drug Discovery | journal | 1.236 Q1 | 77 | 96 | 300 | 9663 | 1208 | 298 | 3.75 | 100.66 | |
31 | Current Topics in Medicinal Chemistry | journal | 0.750 Q2 | 127 | 219 | 708 | 21937 | 2123 | 628 | 2.93 | 100.17 | |
32 | Current Drug Targets | journal | 1.219 Q1 | 112 | 177 | 486 | 17651 | 1576 | 451 | 3.19 | 99.72 | |
33 | RSC Drug Discovery Series | book series | 0.101 Q4 | 11 | 121 | 18 | 12001 | 0 | 16 | 0.00 | 99.18 | |
34 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.392 Q3 | 29 | 7 | 64 | 683 | 84 | 60 | 1.03 | 97.57 | |
35 | Expert Opinion on Therapeutic Targets | journal | 1.953 Q1 | 101 | 131 | 384 | 12752 | 1804 | 372 | 4.49 | 97.34 | |
36 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 52 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | |
37 | Neurotherapeutics | journal | 2.507 Q1 | 129 | 75 | 217 | 7269 | 1243 | 203 | 5.10 | 96.92 | |
38 | Issues in Toxicology | book series | 0.131 Q4 | 17 | 39 | 166 | 3732 | 41 | 152 | 0.22 | 95.69 | |
39 | Current Pharmacology Reports | journal | 29 | 42 | 0 | 3997 | 0 | 0 | 0.00 | 95.17 | ||
40 | Journal of Receptor, Ligand and Channel Research | journal | 0.223 Q3 | 11 | 5 | 13 | 470 | 11 | 13 | 0.64 | 94.00 | |
41 | Toxics | journal | 40 | 26 | 34 | 2421 | 42 | 33 | 1.24 | 93.12 | ||
42 | Antibodies | journal | 0.111 Q4 | 37 | 22 | 66 | 2044 | 114 | 64 | 1.78 | 92.91 | |
43 | Orphan Drugs: Research and Reviews | journal | 0.111 Q4 | 4 | 10 | 2 | 924 | 0 | 2 | 0.00 | 92.40 | |
44 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.134 Q4 | 16 | 25 | 79 | 2307 | 17 | 74 | 0.27 | 92.28 | |
45 | Expert Opinion on Drug Delivery | journal | 1.397 Q1 | 126 | 134 | 390 | 12297 | 2122 | 384 | 5.49 | 91.77 | |
46 | Vaccines | journal | 0.882 Q2 | 67 | 51 | 44 | 4651 | 82 | 42 | 1.86 | 91.20 | |
47 | Current Molecular Pharmacology | journal | 1.354 Q1 | 46 | 35 | 77 | 3169 | 231 | 67 | 2.03 | 90.54 | |
48 | Nano Today | journal | 5.956 Q1 | 167 | 64 | 195 | 5748 | 2095 | 126 | 9.12 | 89.81 | |
49 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.264 Q2 | 25 | 8 | 35 | 717 | 42 | 0 | 1.59 | 89.63 | |
50 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.211 Q1 | 48 | 27 | 70 | 2347 | 254 | 66 | 3.80 | 86.93 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®